187 related articles for article (PubMed ID: 2709320)
21. Kinetics and mechanisms of etodolac degradation in aqueous solutions.
Lee YJ; Padula J; Lee HK
J Pharm Sci; 1988 Jan; 77(1):81-6. PubMed ID: 2964523
[TBL] [Abstract][Full Text] [Related]
22. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
Mbah CJ
Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
[TBL] [Abstract][Full Text] [Related]
23. Degradation kinetics and mechanisms of moricizine hydrochloride in acidic medium.
King SP; Sigvardson KW; Dudzinski J; Torosian G
J Pharm Sci; 1992 Jun; 81(6):586-91. PubMed ID: 1522500
[TBL] [Abstract][Full Text] [Related]
24. Kinetics and mechanism of degradation of cefotaxime sodium in aqueous solution.
Berge SM; Henderson NL; Frank MJ
J Pharm Sci; 1983 Jan; 72(1):59-63. PubMed ID: 6298400
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical properties of CWJ-a-5, a new antitumor 3-arylisoquinoline derivative.
Kim KE; Cho WJ; Kim TS; Kang BH; Chang SJ; Lee CH; Kim DD
Drug Dev Ind Pharm; 2002 Aug; 28(7):889-95. PubMed ID: 12236074
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids.
Taylor R; Sunderland B; Luna G; Czarniak P
Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100
[TBL] [Abstract][Full Text] [Related]
27. Effects of alkali and simulated gastric and intestinal fluids on danazol stability.
Gadkariem EA; El-Obeid HA; Abounassif MA; Ahmed SM; Ibrahim KE
J Pharm Biomed Anal; 2003 Mar; 31(4):743-51. PubMed ID: 12644201
[TBL] [Abstract][Full Text] [Related]
28. Isoxazoles. 10. Degradation and enolization kinetics of 4-aminoisoxazolyl-1,2-naphthoquinone in basic aqueous solution.
Ortiz CS; de Bertorello MM
J Pharm Sci; 1995 Jun; 84(6):783-5. PubMed ID: 7562423
[TBL] [Abstract][Full Text] [Related]
29. Kinetics and mechanism of cymoxanil degradation in buffer solutions.
Morrica P; Trabue S; Anderson JJ; Lawler S; Seccia S; Fidente P; Swain RS; Mattson SL
J Agric Food Chem; 2004 Jan; 52(1):99-104. PubMed ID: 14709020
[TBL] [Abstract][Full Text] [Related]
30. Degradation kinetics and mechanism of N6-[(dimethylamino)methylene]mitomycin C in aqueous solutions.
Chen CM; Coppola WP; Johns WH; Bogardus JB; Lipper RA
J Pharm Sci; 1986 Feb; 75(2):208-10. PubMed ID: 3958935
[TBL] [Abstract][Full Text] [Related]
31. Degradation kinetics of the new antibacterial fluoroquinolone derivative, orbifloxacin, in aqueous solution.
Morimura T; Ohno T; Matsukura H; Nobuhara Y
Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1052-4. PubMed ID: 7641305
[TBL] [Abstract][Full Text] [Related]
32. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
Parasrampuria J; Gupta VD
J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
[TBL] [Abstract][Full Text] [Related]
33. Solution stability of ciclosidomine.
Carney CF
J Pharm Sci; 1987 May; 76(5):393-7. PubMed ID: 3656101
[TBL] [Abstract][Full Text] [Related]
34. The influence of pH and temperature on the degradation kinetics of 4-methoxy-2-[3-(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c] pyridine in aqueous solutions.
Muszalska I; WituĊa K
Acta Pol Pharm; 2005; 62(2):83-8. PubMed ID: 16161346
[TBL] [Abstract][Full Text] [Related]
35. Stability of lidocaine in aqueous solution: effect of temperature, pH, buffer, and metal ions on amide hydrolysis.
Powell MF
Pharm Res; 1987 Feb; 4(1):42-5. PubMed ID: 3508528
[TBL] [Abstract][Full Text] [Related]
36. Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine.
Kirsch LE; Notari RE
J Pharm Sci; 1984 Jul; 73(7):896-902. PubMed ID: 6206222
[TBL] [Abstract][Full Text] [Related]
37. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.
Oliyai C; Borchardt RT
Pharm Res; 1993 Jan; 10(1):95-102. PubMed ID: 8430066
[TBL] [Abstract][Full Text] [Related]
38. The aqueous stability of bupropion.
O'Byrne PM; Williams R; Walsh JJ; Gilmer JF
J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024
[TBL] [Abstract][Full Text] [Related]
39. Olanzapine degradation kinetics in aqueous solution.
Mbah CJ
Pharmazie; 2011 Mar; 66(3):168-70. PubMed ID: 21553645
[TBL] [Abstract][Full Text] [Related]
40. Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin.
Fabre H; Eddine NH; Berge G
J Pharm Sci; 1984 May; 73(5):611-8. PubMed ID: 6330342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]